Sam Hofmans

690 total citations
7 papers, 541 citations indexed

About

Sam Hofmans is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Sam Hofmans has authored 7 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Sam Hofmans's work include Cell death mechanisms and regulation (4 papers), interferon and immune responses (2 papers) and Cancer-related Molecular Pathways (2 papers). Sam Hofmans is often cited by papers focused on Cell death mechanisms and regulation (4 papers), interferon and immune responses (2 papers) and Cancer-related Molecular Pathways (2 papers). Sam Hofmans collaborates with scholars based in Belgium, Germany and South Korea. Sam Hofmans's co-authors include Koen Augustyns, Peter Vandenabeele, Sofie Martens, Pieter Van der Veken, Wim Declercq, Tom Vanden Berghe, Jurgen Joossens, Kenneth Goossens, Hans De Winter and Nozomi Takahashi and has published in prestigious journals such as Journal of Medicinal Chemistry, Trends in Pharmacological Sciences and Cell Death and Disease.

In The Last Decade

Sam Hofmans

7 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sam Hofmans Belgium	7	387	173	154	137	98	7	541
Swati Dhar United States	15	566 1.5×	97 0.6×	284 1.8×	121 0.9×	210 2.1×	22	866
Benxin Hou China	9	352 0.9×	225 1.3×	188 1.2×	45 0.3×	98 1.0×	11	520
Erik Harris United States	10	425 1.1×	78 0.5×	93 0.6×	71 0.5×	215 2.2×	12	626
You-Take Oh United States	14	506 1.3×	232 1.3×	94 0.6×	81 0.6×	251 2.6×	23	672
Yiqian Liang China	14	329 0.9×	61 0.4×	148 1.0×	84 0.6×	76 0.8×	34	511
Andreas Hedblom United States	11	332 0.9×	84 0.5×	123 0.8×	116 0.8×	109 1.1×	15	554
Erica Mina Italy	6	380 1.0×	72 0.4×	302 2.0×	63 0.5×	81 0.8×	6	607
Mercè Padró Spain	5	421 1.1×	115 0.7×	305 2.0×	61 0.4×	124 1.3×	5	581
Vojo Vukovic United States	7	277 0.7×	99 0.6×	81 0.5×	54 0.4×	125 1.3×	13	440

Countries citing papers authored by Sam Hofmans

Since Specialization

Citations

This map shows the geographic impact of Sam Hofmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Hofmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Hofmans more than expected).

Fields of papers citing papers by Sam Hofmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Hofmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Hofmans. The network helps show where Sam Hofmans may publish in the future.

Co-authorship network of co-authors of Sam Hofmans

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Hofmans. A scholar is included among the top collaborators of Sam Hofmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Hofmans. Sam Hofmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Martens, Sofie, Sam Hofmans, Wim Declercq, Koen Augustyns, & Peter Vandenabeele. (2020). Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs. Trends in Pharmacological Sciences. 41(3). 209–224. 125 indexed citations

2.

Martens, Sofie, Vera Goossens, Sam Hofmans, et al.. (2018). RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680). Cell Death and Disease. 9(2). 211–211. 49 indexed citations

3.

Coillie, Samya Van, Sam Hofmans, Dries Van Rompaey, et al.. (2018). Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy. Journal of Medicinal Chemistry. 61(22). 10126–10140. 116 indexed citations

4.

Hofmans, Sam, Sofie Martens, Dries Van Rompaey, et al.. (2018). Tozasertib Analogues as Inhibitors of Necroptotic Cell Death. Journal of Medicinal Chemistry. 61(5). 1895–1920. 39 indexed citations

5.

Hofmans, Sam, et al.. (2018). Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis. Expert Opinion on Drug Discovery. 13(6). 477–488. 28 indexed citations

6.

Martens, Sofie, Manhyung Jeong, Wulf Tonnus, et al.. (2017). Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury. Cell Death and Disease. 8(6). e2904–e2904. 79 indexed citations

7.

Hofmans, Sam, Tom Vanden Berghe, Behrouz Hassannia, et al.. (2015). Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties. Journal of Medicinal Chemistry. 59(5). 2041–2053. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact